What gaps remain in the HIV cascade of care? Results of a population-based survey in Nsanje District, Malawi.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
20
07
2020
accepted:
25
02
2021
entrez:
22
4
2021
pubmed:
23
4
2021
medline:
16
9
2021
Statut:
epublish
Résumé
The Malawi Ministry of Health (MoH) has been in collaboration with Médecins sans Frontières (MSF) to increase access to quality HIV care through decentralization of antiretroviral therapy (ART) diagnosis and treatment from hospital to clinics in Nsanje District since 2011. A population-based household survey was implemented to provide information on HIV prevalence and cascade of care to inform and prioritize community-based HIV interventions in the district. A cross-sectional survey was conducted between September 2016 and January 2017. Using two-stage cluster sampling, eligible adult individuals aged ≥15 years living in the selected households were asked to participate. Participants were interviewed and tested for HIV at home. Those tested HIV-positive had their HIV-RNA viral load (VL) measured, regardless of their ART status. All participants tested HIV-positive at the time of the survey were advised to report their HIV test result to the health facility of their choice that MSF was supported in the district. HIV-RNA VL results were made available in this health facility. Among 5,315 eligible individuals, 91.1% were included in the survey and accepted an HIV test. The overall prevalence was 12.1% (95% Confidence Interval (CI): 11.2-13.0) and was higher in women than in men: 14.0% versus 9.5%, P<0.001. Overall HIV-positive status awareness was 80.0% (95%CI: 76.4-83.1) and was associated with sex (P<0.05). Linkage to care was 78.0% (95%CI: 74.3-81.2) and participants in care 76.2% (95%CI: 72.4-79.5). ART coverage among participants aware of their HIV-positive status was 95.3% (95%CI: 92.9-96.9) and was not associated with sex (P = 0.55). Viral load suppression among participants on ART was 89.9% (95%CI: 86.6-92.4) and was not statistically different by sex (p = 0.40). Despite encouraging results in HIV testing coverage, cascade of care, and UNAIDS targets in Nsanje District, some gap remains in the first 90, specifically among men and young adults. Enhanced community engagement and new strategies of testing, such as index testing, could be implemented to identify those who are still undiagnosed, particularly men and young adults.
Identifiants
pubmed: 33886575
doi: 10.1371/journal.pone.0248410
pii: PONE-D-20-22513
pmc: PMC8061928
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0248410Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Trop Med Int Health. 2010 Dec;15(12):1413-20
pubmed: 20958897
Lancet. 1997 Feb 1;349(9048):352-3
pubmed: 9024392
Front Public Health. 2018 Mar 16;6:69
pubmed: 29600244
JAMA. 2019 Feb 5;321(5):451-452
pubmed: 30629090
Sao Paulo Med J. 2014 Dec;132(6):383
pubmed: 25351762
Lancet. 2009 Oct 17;374(9698):1329
pubmed: 19837252
J Int AIDS Soc. 2016 Feb 15;19(1):20673
pubmed: 26894388
PLoS Med. 2011 Oct;8(10):e1001102
pubmed: 21990966
BMC Public Health. 2018 Mar 2;18(1):303
pubmed: 29499668
J Int AIDS Soc. 2020 Sep;23(9):e25613
pubmed: 32969602
AIDS Behav. 2013 Nov;17(9):2946-53
pubmed: 23142856
Sex Transm Dis. 2019 Jun;46(6):416-421
pubmed: 31095104
N Engl J Med. 2000 Mar 30;342(13):921-9
pubmed: 10738050
PLoS One. 2017 Oct 12;12(10):e0186316
pubmed: 29023510
Lancet Infect Dis. 2011 Jul;11(7):525-32
pubmed: 21546309
AIDS. 2009 Jul 17;23(11):1397-404
pubmed: 19381076
AIDS. 2014 Mar 27;28(6):927-9
pubmed: 24499955
AIDS Res Hum Retroviruses. 2013 Feb;29(2):384-90
pubmed: 22935078
N Engl J Med. 2006 Feb 2;354(5):437-40
pubmed: 16452553
Lancet. 2010 Aug 14;376(9740):532-9
pubmed: 20638713
AIDS. 2015 Jul 31;29(12):1557-65
pubmed: 26244395
J Int AIDS Soc. 2015 May 29;18:19918
pubmed: 26028155
AIDS. 2016 Nov 13;30(17):2685-2695
pubmed: 27782965
AIDS. 2018 Jan 28;32(3):363-369
pubmed: 29194115
PLoS One. 2013 Oct 15;8(10):e77101
pubmed: 24143205
PLoS One. 2017 Oct 3;12(10):e0185699
pubmed: 28973035
PLoS Med. 2017 Apr 11;14(4):e1002262
pubmed: 28399122
Trop Med Int Health. 2016 Nov;21(11):1442-1451
pubmed: 27714902
PLoS One. 2018 Nov 26;13(11):e0207656
pubmed: 30475865
J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):411-418
pubmed: 27243903
BMC Public Health. 2009 Jun 05;9:174
pubmed: 19500373
PLoS One. 2015 Mar 31;10(3):e0122783
pubmed: 25826655
Curr HIV/AIDS Rep. 2009 Nov;6(4):217-23
pubmed: 19849965
BMC Infect Dis. 2017 Sep 29;17(1):653
pubmed: 28969607